Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman

AIDS. 2019 Dec 1;33(15):2443-2444. doi: 10.1097/QAD.0000000000002360.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects
  • Humans
  • Maraviroc / administration & dosage
  • Maraviroc / pharmacokinetics*
  • Milk, Human / chemistry*
  • Plasma / chemistry*
  • Time Factors

Substances

  • Anti-HIV Agents
  • Maraviroc